Decision Readiness Index (DRI) Β· Decision Readiness Level (DRL) Β· ML-augmented multi-objective optimisation for Ukrainian pharmaceutical portfolios
| Dimension | Weight | What it measures |
|---|---|---|
| R1 β Data Quality | 25% | Completeness, consistency, temporal coverage of SKU data |
| R2 β Market Observability | 25% | Market share visibility, competitive data availability |
| R3 β Forecast Reliability | 20% | ML forecast confidence, MAPE, seasonal stability |
| R4 β Model Applicability | 15% | Portfolio diversity enabling optimisation methods |
| R5 β Environmental Entropy | 15% | Geopolitical / regulatory disruption risk (Ukraine context) |
| DRL | DRI Range | Method | Action |
|---|---|---|---|
| DRL-1 | DRI < 0.25 | Abstain | Flag for data collection; do not optimise |
| DRL-2 | 0.25 β 0.45 | Rule-Based | Heuristic rules (cap growth, floor decline) |
| DRL-3 | 0.45 β 0.65 | LP | Linear programming within safety bounds |
| DRL-4 | 0.65 β 0.80 | CVaR / MVO | Conditional Value-at-Risk mean-variance optimisation |
| DRL-5 | DRI β₯ 0.80 | ML-Augmented | Multi-objective optimisation with ML signal integration |
Each chart shows SKU absolute revenue in UAH. β Historical actual revenue Β· β No rebalance ML forecast (weight unchanged) Β· β HPF rebalanced forecast scaled by weight change ratio (Γrebalance factor). If HPF raises a SKU's weight 2Γ the rebalance line sits 2Γ higher β showing proportional portfolio gain. Bands = P10βP90 confidence range.